Q
BMY icon

QVR’s Bristol-Myers Squibb BMY Stock Holding History

QVR’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4,200
Closed -$302K – 30
2022
Q4 		$302K Sell
4,200
-37,300
-90% -$2.81M 0.03% 80
2022
Q3 		$2.95M Buy
41,500
+12,300
+42% +$892K 0.24% 75
2022
Q2 		$2.25M Sell
29,200
-48,100
-62% -$3.66M 0.16% 87
2022
Q1 		$5.64M Buy
+77,300
New +$5.19M 0.22% 102
2021
Q4 		– Sell
-25,700
Closed -$1.52M – 61
2021
Q3 		$1.52M Buy
25,700
+6,500
+34% +$428K 0.1% 155
2021
Q2 		$1.28M Buy
19,200
+16,400
+586% +$1.07M 0.13% 85
2021
Q1 		$177K Buy
2,800
+700
+33% +$43.6K 0.02% 144
2020
Q4 		$129K Buy
+2,100
New +$129K 0.01% 91

Other funds holding BMY

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
ORIO
Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
UBP
Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return

QVR's BMY Position: Q2 2026 in Review

QVR sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 7,811 shares — an estimated $474K sold.

QVR first reported a position in BMY in Q4 2020 and held it in 6 quarters. The position peaked at $783K in Q4 2025. 440 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • QVR reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
  • QVR sold 7,811 Bristol-Myers Squibb shares in Q2 2026, an estimated $474K.
  • QVR first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 6 quarters.
  • QVR's Bristol-Myers Squibb position peaked at $783K in Q4 2025.
  • 440 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on QVR's 13F filing for Q2 2026.